Nykode Therapeutics AS
(OSL:NYKD)
kr
6.315
0.54 (9.35%)
Market Cap: 2.06 Bil
Enterprise Value: 666.43 Mil
PE Ratio: 0
PB Ratio: 1.28
GF Score: 57/100 Nykode Therapeutics AS (OSL:NYKD) Transcripts
- Q2 2024 Nykode Therapeutics ASA Earnings Call Transcript4 days agokr5.56 (-47.04%)Earnings
- Q1 2024 Nykode Therapeutics ASA Earnings Call TranscriptMay 14, 2024kr14.35 (+2.14%)Earnings
- Q4 2023 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2024kr16.94 (-5.84%)Earnings
- Q2 2023 Nykode Therapeutics ASA Earnings Call TranscriptAug 23, 2023kr26.58 (-0.23%)Earnings
- Nykode Therapeutics ASA at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Nykode Therapeutics ASA Earnings Call TranscriptMay 12, 2023kr26.78 (+5.68%)Earnings
- Q4 2022 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2023kr26.42 (-2.51%)Earnings
- Nykode Therapeutics ASA Corporate Call TranscriptDec 20, 2022
- Q3 2022 Nykode Therapeutics ASA Earnings Call TranscriptNov 23, 2022kr25.18 (-1.79%)Earnings
- Nykode Therapeutics ASA at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Nykode Therapeutics AS at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Vaccibody AS Call to Discuss License Agreement with Adaptive Biotechnologies Corp TranscriptJul 12, 2021
- 1